Lipoprotein Metabolism Indicators Improve Cardiovascular Risk Prediction

Abstract

Two calculated VLDL metabolism indicators significantly improved cardiovascular risk prediction. These indicators may help to reduce prescription of unnecessary cholesterol-lowering medication, reducing costs and possible side-effects. For clinical application, further validation is required.